At Next Genomix Laboratories, we are committed to providing our patients with the best possible care. One way we do this is by evaluating a patient's genetic propensity to experience a drug-to-drug interaction or to be non-responsive to certain medication classes.

This information is invaluable to clinicians, whether they are initiating therapy or evaluating a patient's progress. We have a team of experts who evaluate genes and variants to create a report on drug classes and pharmacologic agents. Here are four things all of our patients should know before using our services, and if you have questions, contact us today!